The abstract is read at the publisher; the summary is JClub's.
In nulliparous individuals in Sweden, intrauterine instillation of 10 mL mepivacaine (20 mg/mL) reduced clinician-adjusted IUD placement pain by 14.8 mm versus placebo.
- Why it matters: Pain during IUD placement is common and can deter uptake, so testing whether a simple intrauterine analgesic improves comfort supports better contraceptive decision-making.
- What they did: In a multicenter, double-blind randomized placebo-controlled trial (May 2021–June 2024), 370 nulliparous participants received mepivacaine or sodium chloride via a hydrosonography catheter 2 minutes before placement.
- The result: Mean pain was 43.8 mm with mepivacaine versus 58.6 mm with placebo (P < .001), and tolerable pain was reported more often with mepivacaine (98.3% vs 91.4%; NNT 15).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.